or Try an Advanced Search...

    Cell Product Stocks List

    Symbol Grade Name % Change
    SGMO A Sangamo BioSciences, Inc. 10.59
    MESO B Mesoblast Limited 1.19
    NTLA F Intellia Therapeutics, Inc. 4.15
    CLLS F Cellectis S.A. 1.12
    BCLI F Brainstorm Cell Therapeutics Inc. -0.53
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Adult Stem Cell Biology Blastoma Bone Bone Marrow Chimeric Antigen Receptor Emerging Technologies Glioblastoma Life Sciences Medicine Molecular Biology Stem Cell Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Amyloid Amyloidosis Amyotrophic Lateral Sclerosis Antitrypsin Deficiency

    Related ETFs - A few ETFs which own one or more of the above listed Cell Product stocks.

    Symbol Grade Name Weight
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.81
    GNOM F Global X Genomics & Biotechnology ETF 2.82
    ARKK B ARK Innovation ETF 2.25
    HRTS D Tema Cardiovascular and Metabolic ETF 2.11
    CANC C Tema Oncology ETF 2.05
    View all Cell Product ETFs...
    Compare ETFs
    Compare ARKG to HRTS Compare ARKK to CANC Compare GNOM to HRTS

        Cell Product Stocks Recent News

        Date Stock Title
        Nov 1 SGMO individual investors who own 55% along with institutions invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) saw increase in their holdings value last week
        Oct 31 NTLA Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024
        Oct 31 NTLA Intellia Therapeutics (NTLA): Promising Gene Editing Stock with CRISPR-Cas9 Therapies
        Oct 30 MESO Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024
        Oct 30 MESO When Will Mesoblast Limited (ASX:MSB) Become Profitable?
        Oct 30 NTLA Reasons For Intellia Therapeutics Stock Plunge Are Flimsy, But Don't Buck Mr. Market
        Oct 29 NTLA Looking Into Intellia Therapeutics's Recent Short Interest
        Oct 26 NTLA Intellia Therapeutics Advances with Promising Phase 2 Results
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Adult Stem Cell Biology Blastoma Bone Bone Marrow Chimeric Antigen Receptor Emerging Technologies Glioblastoma Life Sciences Medicine Molecular Biology Stem Cell Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Amyloid Amyloidosis Amyotrophic Lateral Sclerosis Antitrypsin Deficiency
        Cell Product

        Cell product is a term used to describe the process of producing a product from a cell culture. This process involves culturing cells in a laboratory setting and then harvesting the cells to create a product. Cell products can range from pharmaceuticals and biologics to food and cosmetics.

        Browse All Tags